It is well known that cancer patients die from cancer when it spreads unchecked and interferes with the normal function of other organs.
MammoCheck and IgoCheck are the only serum-based cancer monitoring tests specifically available to identify recurrence at an early stage, years ahead of imaging results, when treatment is most successful. It is recommended to schedule frequent monitoring to detect any relapse and take adequate measures in time.
When cancer cells are identified, preventative therapeutic measures are more effective to eradicate recurrent cancer and keep you healthy.
Sometimes primary treatments for cancer do not eradicate all the cancer cells and a few can remain and "seed" new growths and tumors in other parts of the body. When regular monitoring is not in place, cancer can return without warning, either in the original diseased organ and/or in different organs (metastasis), making it much harder to control the disease.